The Operating System
for Clinical Development
De-risk every program decision - and prove it. Aurora gives clinical development and feasibility teams the intelligence to design, de-risk, and defend trial strategy across the portfolio - and the evidence trail to govern the CROs who execute it.
Less Time. More Capability.
Study simulations, country rankings, multi-cohort designs, and reports built in the app - with time savings measured end to end in live deployments, not cherry-picked.
The Aurora Workflow
Five steps that take you from raw data to a decision-ready deliverable - one workflow, whichever module you run. Select a step to see what happens inside it.
Bring the data in - upload your own datasets or import directly from Trial Core™ and Plume™. Drag-and-drop files combine into a single analysis-ready dataset, so the data chase becomes a data check.
60% faster | data gathering & entry, measured in a live CRO workflow
> Analysis-ready datasetMeasured end to end in a live CRO deployment: rankings 53% faster - more than a full working week returned to the team, every month.
Proof That Changes Minds
Real results from real deployments. Aurora Analytica™ is measured by the outcomes it delivers.
0%
Faster Country Rankings
A global CRO measured their workflow end to end: 8 h 45 min down to 4 h 10 min per ranking - while confidence rose from 3/5 to 4/5, scoring roughly twice as many criteria.
0h 40m
Saved Per Ranking
At 10-20 rankings a month, that's more than a full working week returned to the team, every month - capacity that goes back into strategy, not data wrangling.
0.5/10
Client Satisfaction
Enterprise CRO customers rate their likelihood to recommend Aurora 8.5/10 on average - alongside high marks for experience, time saved, and cost reduction.
0K+
Trial Records
The Trial Core™ database aggregates over 550,000 trial records from 7+ global directories - AI-enriched and analysis-ready in hours instead of days.
ESMO
Published
AI-driven feasibility methodology peer-reviewed and presented at one of the world's leading oncology conferences.
EIC
Accelerator Stage 1
Selected by the European Innovation Council - one of Europe's most competitive deep-tech funding programs.
8.5 / 10
Client Satisfaction
Likelihood to recommend | Averaged across enterprise CRO customers
"
Feasibility Team
Global CRO
Evaluator
European Innovation Council (EIC)
Read testimonial >
Associate Director, Data Intelligence
Global CRO
Read testimonial >
Past CEO
CRO (Nordics)
Read testimonial >
"
Feasibility Team
Global CRO
Associate Director, Data Intelligence
Global CRO
Read testimonial >
Evaluator
European Innovation Council (EIC)
Read testimonial >
Past CEO
CRO (Nordics)
Read testimonial >
Built by People Who Know Clinical Trials
Three decades of CRO experience, deep technical expertise, and a shared obsession with making clinical trial strategy smarter.
Ola
Chairman30+ years in clinical research and CRO leadership. As Founder of LINK Medical Research, Ola brings unmatched expertise in trial operations, sponsor relationships, and CRO commercialisation - the strategic foundation that makes Aurora's vision possible.
View on LinkedIn
Bhav
CEOFounder and architect of Aurora's decision intelligence platform. 10+ years leading CRO feasibility, analytics, and data-driven strategy - the expertise that shaped every module of the Aurora Suite™ from first principles.
View on LinkedIn
Espen
CTO10+ years building secure, AI-driven software systems in regulated industries. Architect of scalable distributed platforms and intelligent automation frameworks - the technical force behind Aurora's enterprise-grade infrastructure.
View on LinkedInLatest from Aurora Analytica
Case studies, publications, and company milestones from the team building the future of clinical trial strategy.
More Articles
Human First. AI Where It Counts.
AI companies carry a stigma right now, and the worry behind it deserves a serious answer. Co-founder & CEO Bhavish Lekh on why Aurora builds on a human foundation, keeps a person at the wheel, and wants technology that opens doors for the next generation.
Read Article >Monte Carlo Simulations Have Come to Clinical Study Execution
The riskiest decisions in a pivotal program are locked in before the first patient is enrolled - usually on a single number. Here's why a proven method from finance and aerospace changes that.
Read Article >How Far Can AI Chat Agents Go With Clinical Trial Data?
AI chat agents now connect to ClinicalTrials.gov - but can they replace purpose-built feasibility tools? Co-founder Bhavish Lekh tests ChatGPT-style agents on a real 255-trial NSCLC analysis and finds the architectural limits.
Read Article >Why John Hillier Joining Our Advisory Board Matters
John Hillier, Head of Feasibility Strategy & Site Intelligence at Pfizer, joins the Aurora Analytica Advisory Board - bringing 25+ years of clinical trial optimisation, CRO and pharma-side feasibility leadership, and a shared vision for better decision-making in clinical development.
Read Article >The Story Behind Aurora Analytica
After a decade leading feasibility operations across 400+ clinical studies, Co-founder & CEO Bhavish Lekh shares the journey from idea to platform - and what's next for Aurora Analytica.
Read Article >A Global CRO Streamlines Trial Strategy and Boosts RFP Quality with Aurora Analytica™
A prominent global CRO adopted Aurora Analytica™ to modernize its pre-award landscape analysis. After hands-on use across multiple projects, they rated the platform 10/10 for satisfaction.
Read Article >Aurora Analytica Welcomes Espen Gudmundsen as CTO
Espen Gudmundsen joins Aurora Analytica as Chief Technology Officer, bringing 10+ years of expertise in software development, AI, and cybersecurity.
Read Article >Aurora Analytica Awarded 1.2 Million NOK in Innovation Grants from Innovation Norway
Aurora Analytica™ has received a total of 1.2 million NOK in grants from Innovation Norway since 2024, accelerating development of the Aurora Suite™.
Read Article >Breaking Down Silos: A User-Defined Approach to Global Feasibility
How Aurora Analytica™ transforms fragmented data into connected, actionable clinical trial intelligence - going beyond siloed databases.
Read Article >Decision Engines™ vs Data Tools: Navigating Clinical Trials Smarter
Why a GPS beats hundreds of paper maps - exploring the difference between traditional data tools and Aurora's Decision Engines™.
Read Article >Aurora Analytica Recognized by the EIC for Its Ground-breaking Innovation
The European Innovation Council described the Aurora Suite as "a superior solution compared to existing fragmented systems" and a "highly novel, deep tech breakthrough."
Read Article >Aurora Analytica Awarded Innovation Norway Start-up 2 Grant
Aurora Analytica has been awarded the prestigious Start-up 2 grant from Innovation Norway, validating our technology and mission.
Read Article >Delivering New Clinical Trial Wins for CROs
We supported a mid-size CRO through a full feasibility and strategy process, resulting in a won global clinical trial and a client satisfaction rating of 9.1/10.
Read Article >Optimizing Phase III Trials in Pancreatic Cancer - ESMO Poster 2024
Our ESMO 2024 poster showcases how the Aurora Suite™ optimizes Phase III trial strategy in pancreatic cancer - delivering 200%+ enrolment improvement and 80%+ time savings.
Read Article >Human First. AI Where It Counts.
AI companies carry a stigma right now, and the worry behind it deserves a serious answer. Co-founder & CEO Bhavish Lekh on why Aurora builds on a human foundation, keeps a person at the wheel, and wants technology that opens doors for the next generation.
Read Article >Monte Carlo Simulations Have Come to Clinical Study Execution
The riskiest decisions in a pivotal program are locked in before the first patient is enrolled - usually on a single number. Here's why a proven method from finance and aerospace changes that.
Read Article >How Far Can AI Chat Agents Go With Clinical Trial Data?
AI chat agents now connect to ClinicalTrials.gov - but can they replace purpose-built feasibility tools? Co-founder Bhavish Lekh tests ChatGPT-style agents on a real 255-trial NSCLC analysis and finds the architectural limits.
Read Article >Why John Hillier Joining Our Advisory Board Matters
John Hillier, Head of Feasibility Strategy & Site Intelligence at Pfizer, joins the Aurora Analytica Advisory Board - bringing 25+ years of clinical trial optimisation, CRO and pharma-side feasibility leadership, and a shared vision for better decision-making in clinical development.
Read Article >The Story Behind Aurora Analytica
After a decade leading feasibility operations across 400+ clinical studies, Co-founder & CEO Bhavish Lekh shares the journey from idea to platform - and what's next for Aurora Analytica.
Read Article >A Global CRO Streamlines Trial Strategy and Boosts RFP Quality with Aurora Analytica™
A prominent global CRO adopted Aurora Analytica™ to modernize its pre-award landscape analysis. After hands-on use across multiple projects, they rated the platform 10/10 for satisfaction.
Read Article >Aurora Analytica Welcomes Espen Gudmundsen as CTO
Espen Gudmundsen joins Aurora Analytica as Chief Technology Officer, bringing 10+ years of expertise in software development, AI, and cybersecurity.
Read Article >Aurora Analytica Awarded 1.2 Million NOK in Innovation Grants from Innovation Norway
Aurora Analytica™ has received a total of 1.2 million NOK in grants from Innovation Norway since 2024, accelerating development of the Aurora Suite™.
Read Article >Breaking Down Silos: A User-Defined Approach to Global Feasibility
How Aurora Analytica™ transforms fragmented data into connected, actionable clinical trial intelligence - going beyond siloed databases.
Read Article >Decision Engines™ vs Data Tools: Navigating Clinical Trials Smarter
Why a GPS beats hundreds of paper maps - exploring the difference between traditional data tools and Aurora's Decision Engines™.
Read Article >Aurora Analytica Recognized by the EIC for Its Ground-breaking Innovation
The European Innovation Council described the Aurora Suite as "a superior solution compared to existing fragmented systems" and a "highly novel, deep tech breakthrough."
Read Article >Aurora Analytica Awarded Innovation Norway Start-up 2 Grant
Aurora Analytica has been awarded the prestigious Start-up 2 grant from Innovation Norway, validating our technology and mission.
Read Article >Delivering New Clinical Trial Wins for CROs
We supported a mid-size CRO through a full feasibility and strategy process, resulting in a won global clinical trial and a client satisfaction rating of 9.1/10.
Read Article >Optimizing Phase III Trials in Pancreatic Cancer - ESMO Poster 2024
Our ESMO 2024 poster showcases how the Aurora Suite™ optimizes Phase III trial strategy in pancreatic cancer - delivering 200%+ enrolment improvement and 80%+ time savings.
Read Article >Get Started
Ready to Transform Your Workflow?
When stakeholders ask "how confident are we?", "it's our best estimate" isn't a defensible answer. Aurora gives clinical development teams simulation-backed, auditable trial strategy - with a Probability of Success behind every plan.
Get In Touch
Let's talk about your clinical trial strategy
Whether you're a CRO looking to modernize feasibility workflows or a pharma sponsor seeking smarter site selection - we're here to help.
info@aurora-analytica.com
Location
Oslo, Norway
53% Faster
Country rankings in less than half the time
30m to 2.5h
A complete platform run, end to end
8.5/10 Satisfaction
Enterprise CRO Customers